488 related articles for article (PubMed ID: 10802656)
1. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.
Holland EC; Celestino J; Dai C; Schaefer L; Sawaya RE; Fuller GN
Nat Genet; 2000 May; 25(1):55-7. PubMed ID: 10802656
[TBL] [Abstract][Full Text] [Related]
2. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
[TBL] [Abstract][Full Text] [Related]
3. Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma.
Sonoda Y; Ozawa T; Aldape KD; Deen DF; Berger MS; Pieper RO
Cancer Res; 2001 Sep; 61(18):6674-8. PubMed ID: 11559533
[TBL] [Abstract][Full Text] [Related]
4. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
5. c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells.
Cui J; Han SY; Wang C; Su W; Harshyne L; Holgado-Madruga M; Wong AJ
Cancer Res; 2006 Oct; 66(20):10024-31. PubMed ID: 17047065
[TBL] [Abstract][Full Text] [Related]
6. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
Charest A; Wilker EW; McLaughlin ME; Lane K; Gowda R; Coven S; McMahon K; Kovach S; Feng Y; Yaffe MB; Jacks T; Housman D
Cancer Res; 2006 Aug; 66(15):7473-81. PubMed ID: 16885344
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors.
Faury D; Nantel A; Dunn SE; Guiot MC; Haque T; Hauser P; Garami M; Bognár L; Hanzély Z; Liberski PP; Lopez-Aguilar E; Valera ET; Tone LG; Carret AS; Del Maestro RF; Gleave M; Montes JL; Pietsch T; Albrecht S; Jabado N
J Clin Oncol; 2007 Apr; 25(10):1196-208. PubMed ID: 17401009
[TBL] [Abstract][Full Text] [Related]
8. Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma.
Sonoda Y; Ozawa T; Hirose Y; Aldape KD; McMahon M; Berger MS; Pieper RO
Cancer Res; 2001 Jul; 61(13):4956-60. PubMed ID: 11431323
[TBL] [Abstract][Full Text] [Related]
9. Essential role for Ras signaling in glioblastoma maintenance.
Holmen SL; Williams BO
Cancer Res; 2005 Sep; 65(18):8250-5. PubMed ID: 16166301
[TBL] [Abstract][Full Text] [Related]
10. Cooperative translational control of gene expression by Ras and Akt in cancer.
Parsa AT; Holland EC
Trends Mol Med; 2004 Dec; 10(12):607-13. PubMed ID: 15567331
[TBL] [Abstract][Full Text] [Related]
11. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival.
Mizoguchi M; Betensky RA; Batchelor TT; Bernay DC; Louis DN; Nutt CL
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1181-8. PubMed ID: 17146292
[TBL] [Abstract][Full Text] [Related]
12. Ras pathway signals are required for notch-mediated oncogenesis.
Fitzgerald K; Harrington A; Leder P
Oncogene; 2000 Aug; 19(37):4191-8. PubMed ID: 10980592
[TBL] [Abstract][Full Text] [Related]
13. Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling.
Villalonga P; López-Alcalá C; Bosch M; Chiloeches A; Rocamora N; Gil J; Marais R; Marshall CJ; Bachs O; Agell N
Mol Cell Biol; 2001 Nov; 21(21):7345-54. PubMed ID: 11585916
[TBL] [Abstract][Full Text] [Related]
14. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
[TBL] [Abstract][Full Text] [Related]
15. Expression of transketolase-like 1 and activation of Akt in grade IV glioblastomas compared with grades II and III astrocytic gliomas.
Völker HU; Hagemann C; Coy J; Wittig R; Sommer S; Stojic J; Haubitz I; Vince GH; Kämmerer U; Monoranu CM
Am J Clin Pathol; 2008 Jul; 130(1):50-7. PubMed ID: 18550470
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
Portis T; Longnecker R
Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
[TBL] [Abstract][Full Text] [Related]
17. Ras inhibition amplifies cisplatin sensitivity of human glioblastoma.
Messina S; Leonetti C; De Gregorio G; Affatigato V; Ragona G; Frati L; Zupi G; Santoni A; Porcellini A
Biochem Biophys Res Commun; 2004 Jul; 320(2):493-500. PubMed ID: 15219856
[TBL] [Abstract][Full Text] [Related]
18. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells.
Hoover RR; Gerlach MJ; Koh EY; Daley GQ
Oncogene; 2001 Sep; 20(41):5826-35. PubMed ID: 11593388
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes.
Rajasekhar VK; Viale A; Socci ND; Wiedmann M; Hu X; Holland EC
Mol Cell; 2003 Oct; 12(4):889-901. PubMed ID: 14580340
[TBL] [Abstract][Full Text] [Related]
20. Activation of the anti-apoptotic Akt/protein kinase B pathway in human malignant gliomas in vivo.
Schlegel J; Piontek G; Mennel HD
Anticancer Res; 2002; 22(5):2837-40. PubMed ID: 12530006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
